The aim of this study was to provide evidence of the psychometric properties of the National Eye Institute - Visual Functioning Questionnaire ( VFQ-25 ) for use in a cohort of DME patients who participated in a clinical efficacy and safety trial of pegaptinib sodium ( Macugen ) .
